Citation Impact
Citing Papers
Refractive index tomograms and dynamic membrane fluctuations of red blood cells from patients with diabetes mellitus
2017
Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
2001 Standout
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
2004
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
1997 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Medical Therapies for Uterine Fibroids – A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials
2016
Comparative effects of cilostazol and other therapies for intermittent claudication
2001
TREM and TREM-like receptors in inflammation and disease
2009 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Short and long-term effects of smoking on arterial wall properties in habitual smokers
1993
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
1998
Pentoxifylline
1987 Standout
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Antithrombotic Therapy for VTE Disease
2012 Standout
Diabetes and Atherosclerosis
2002 Standout
Prevention of Venous Thromboembolism
2004 Standout
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
2001
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
2020 Standout
Treatment of Intermittent Claudication With Physical Training, Smoking Cessation, Pentoxifylline, or Nafronyl
1999
Oral vasoactive medication in intermittent claudication: utile or futile?
2000
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
COX-2 inhibitors
1999 Standout
Pharmacological Management of Intermittent Claudication
2000
Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis
2008 Standout
Prognosis of community acquired pneumonia (CAP): Value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response
2007 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Medical care and cost outcomes after pentoxifylline treatment for peripheral arterial disease.
1992
Pentoxifylline for Intermittent Claudication
1994
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Pentoxifylline: A New Drug for the Treatment of Intermittent Claudication; Mechanism of Action, Pharmacokinetics, Clinical Efficacy and Adverse Effects
1984
The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum
2011 Standout
Prevention of Post-Operative Thrombosis in Peripheral Arteriopathies. Pentoxifylline vs. Conventional Antiaggregants: A Six-Month Randomized Follow-up Study
1984
Veno-active drugs in the management of chronic venous disease. An international consensus statement: current medical position, prospective views and final resolution.
2005
Phlebotonics for venous insufficiency
2005
Phlebotonics for venous insufficiency
2016
Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study
1986
Effects of Flunarizine and Pentoxifylline on Walking Distance and Blood Rheology in Claudication
1984
Guidelines for the Primary Prevention of Stroke
2014 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
1996
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
1995 Standout
INTERMITTENT CLAUDICATION: A DOUBLE–BLIND CROSSOVER TRIAL OF PENTOXIFYLLINE
1985
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
1992
Occurrence of drugs in German sewage treatment plants and rivers
1998 Standout
Effects of pentoxifylline on central hemodynamics in patients with congestive heart failure
1986
Clinical Pharmacology of Pentoxifylline With Special Reference to Its Hemorrheologic Effect for the Treatment of Intermittent Claudication
1985
On the Therapy of Disturbances of Blood Fluidity
1985
Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.
2000 Standout
Antithrombotic Potential of Pentoxifylline A Hemorheologically Active Drug
1985
Quantitative phase imaging in biomedicine
2018 Standout
Works of M Guerrini being referenced
GnRH Agonist Treatment before Total Laparoscopic Hysterectomy for Large Uteri
2003
Evaluation of erythrocyte morphology as deformability index in patients suffering from vascular diseases, with or without diabetes mellitus: correlation with blood viscosity and intra‐erythrocytic calcium
1998
Strain Gauge Plethysmography in the Study of Circulation of the Limbs
1979
Effect of HR (O-(beta-hydroxyethyl)-rutosides) on the impaired venous function of young females taking oral contraceptives. A strain gauge plethysmographic and clinical open controlled study.
1980
Studies of the Clinical Pharmacology and Therapeutic Efficacy of Pentoxifylline in Peripheral Obstructive Arterial Disease
1984
Length of hospitalization in elderly patients with community-acquired pneumonia
2000
[Calcium dobesilate in the treatment of primary venous insufficiency of the lower limbs. A controlled clinical study].
1990
Placebo Controlled Double Blind Study with Pentoxifylline of Walking Performance in Patients with Intermittent Claudication
1983